FDA NDC Directory · JSON-LD · Markdown

Afinitor Disperz

NDC 0078-0627 · HUMAN PRESCRIPTION DRUG · TABLET, FOR SUSPENSION

Generic nameeverolimus
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryNew Drug Application (innovator) · App NDA203985
Dosage form / routeTABLET, FOR SUSPENSION · ORAL
Active ingredientsEVEROLIMUS (3 mg/1)
Marketing started20120829
Package count1

External sources

Source: openFDA. Public-domain (CC0).